Joseph C. Papa

2018 - Valeant Pharmaceuticals International

In 2018, Joseph C. Papa earned a total compensation of $14.7M as Chief Executive Officer at Valeant Pharmaceuticals International, a 201% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,802,500
Option Awards$1,999,715
Salary$1,500,000
Stock Awards$7,344,927
Other$93,908
Total$14,741,050

Papa received $7.3M in stock awards, accounting for 50% of the total pay in 2018.

Papa also received $3.8M in non-equity incentive plan, $2M in option awards, $1.5M in salary and $93.9K in other compensation.

Rankings

In 2018, Joseph C. Papa's compensation ranked 324th out of 14,244 executives tracked by ExecPay. In other words, Papa earned more than 97.7% of executives.

ClassificationRankingPercentile
All
324
out of 14,244
98th
Division
Manufacturing
113
out of 5,765
98th
Major group
Chemicals And Allied Products
34
out of 2,128
98th
Industry group
Drugs
28
out of 1,817
99th
Industry
Pharmaceutical Preparations
20
out of 1,391
99th

Pay ratio

Joseph C. Papa's Pay$14,741,050
Median Employee's Pay$37,872
Pay Ratio

389

to 1

In 2018, the annual total compensation of Joseph C. Papa was $14,741,050.

The annual total compensation of the median employee at Valeant Pharmaceuticals International was $37,872.

The ratio of Joseph C. Papa's pay to the pay of median employee was therefore 389 to one.

Source: SEC filing on March 18, 2019.

Papa's colleagues

We found four more compensation records of executives who worked with Joseph C. Papa at Valeant Pharmaceuticals International in 2018.

2018

Paul Herendeen

Valeant Pharmaceuticals International

Chief Financial Officer

2018

Thomas Appio

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

2018

Christina Ackermann

Valeant Pharmaceuticals International

General Counsel

2018

Joseph Gordon

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

News

You may also like